RWJ-68023

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameRWJ-68023
Drug Alias NameRWJ-68023
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMotilin receptor antagonists
TargetsMotilin receptor
Therapy Area/IndicationsDyspepsiaIrritable Bowel Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesJohnson & Johnson
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJohnson & Johnson
Active IndicationsN/A
Inactive IndicationsDyspepsiaIrritable Bowel Syndrome

Other Information

ATC CodeN/A
Related LinksN/A